Search
for
Sort by
Research 31–60 of 1000+
- Markers of Venous Thromboembolism Risk in Patients with Alopecia Areata: Is There Anything to Worry about?
- A decade of progress in androgenetic alopecia management: Emerging therapies and multimodal strategies
- An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis
- Upadacitinib in dermatologic therapy: Emerging evidence and expanding indications
- Pathomechanisms of immune-mediated alopecia
- Single-cell sequencing combined with spatial transcriptomics reveals the characteristics of follicle-targeted inflammation patterns in primary cicatricial alopecia
- Alopecia Areata: Understanding the Pathophysiology and Advancements in Treatment Modalities
- Quoi de neuf en dermatologie pédiatrique ?
- Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
- Janus kinase (JAK) inhibitors for the treatment of skin and hair disorders: a review of literature
- 277 An open label pilot clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- Safety of oral JAK inhibitors in treating alopecia areata: a systematic review and network meta-analysis
- Efficacy and safety of different JAK inhibitors in the treatment of alopecia areata: a network meta-analysis
- 331 An open label clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- Treatment of alopecia areata with JAK inhibitors: a review of the literature
- Case Report: Multimodal contact immunotherapy in alopecia areata: long-term clinical experience in the JAK inhibitor era
- Alopecia Areata: Pathogenesis, Diagnosis, and Therapies
- Fractionated CO2 Laser in Combination with Topical Tacrolimus for Chronic Alopecia Areata: A Case Series Study
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- Janus Kinase inhibitors in dermatology: a review
- The Role of Janus Kinase Inhibitors in Dermatology
- Janus kinase inhibitors for alopecia areata: a review of clinical data
- Treatment of alopecia universalis with topical Janus kinase inhibitors – a double blind, placebo, and active controlled pilot study
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- Efficacy of Janus kinase inhibitors in adult patients with alopecia areata
- Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis
- JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician
- [JAK INHIBITORS FOR THE TREATMENT OF ALOPECIA AREATA].
- JAK Inhibitors for Treatment of Alopecia Areata
- The development of oral hairy leukoplakia during JAK inhibitor baricitinib therapy